Nasus Pharma Ltd (NSRX) stock
NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
$2.61−0.05 (-1.88%)
Close on Nov 17, 2026Market cap $23.53MP/E –Yield –
Nasus Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nasus Pharma's price to sales ratio was 0.0× on Nov 11, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.0× | – |
See a number that looks wrong?